Reducing the Blood Pressure-Related Burden of Cardiovascular Disease: Impact of Achievable Improvements in Blood Pressure Prevention and Control
-
2015/10/27
-
Details
-
Personal Author:Avery CL ; Butler KR ; Chakladar S ; Chang PP ; Folsom AR ; Hardy ST ; Heiss G ; Loehr LR ; MacLehose RF ; Matsushita K
-
Description:Background: US blood pressure reduction policies are largely restricted to hypertensive populations and associated benefits are often estimated based on unrealistic interventions. Methods and Results: We used multivariable linear regression to estimate incidence rate differences contrasting the impact of 2 pragmatic hypothetical interventions to reduce coronary heart disease, stroke, and heart failure (HF) incidence: (1) a population-wide intervention that reduced systolic blood pressure by 1 mm Hg and (2) targeted interventions that reduced the prevalence of unaware, untreated, or uncontrolled blood pressure above goal (per Eighth Joint National Committee treatment thresholds) by 10%. In the Atherosclerosis Risk in Communities Study (n=15 744; 45 to 64 years at baseline, 1987-1989), incident coronary heart disease and stroke were adjudicated by physician panels. Incident HF was defined as the first hospitalization with discharge diagnosis code of "428." A 10% proportional reduction in unaware, untreated, or uncontrolled blood pressure above goal resulted in approx. equal to 4.61, 3.55, and 11.01 fewer HF events per 100 000 person-years in African Americans, and 3.77, 1.63, and 4.44 fewer HF events per 100 000 person-years, respectively, in whites. In contrast, a 1 mm Hg population-wide systolic blood pressure reduction was associated with 20.3 and 13.3 fewer HF events per 100 000 person-years in African Americans and whites, respectively. Estimated event reductions for coronary heart disease and stroke were smaller than for HF, but followed a similar pattern for both population-wide and targeted interventions. Conclusions: Modest population-wide shifts in systolic blood pressure could have a substantial impact on cardiovascular disease incidence and should be developed in parallel with interventions targeting populations with blood pressure above goal. [Description provided by NIOSH]
-
Subjects:
-
Keywords:
-
ISSN:2047-9980
-
Document Type:
-
Funding:
-
Genre:
-
Place as Subject:
-
CIO:
-
Topic:
-
Location:
-
Volume:4
-
Issue:10
-
NIOSHTIC Number:nn:20064293
-
Citation:J Am Heart Assoc 2015 Oct; 4(10):e002276
-
Contact Point Address:Shakia T. Hardy, MPH, Cardiovascular Disease Program, Department of Epidemiology, University of North Carolina at Chapel Hill, 137 East Franklin Street, Suite 306-D, Chapel Hill, NC 27514
-
Email:sthardy@live.unc.edu
-
Federal Fiscal Year:2016
-
Performing Organization:University of Minnesota Twin Cities
-
Peer Reviewed:True
-
Start Date:20050701
-
Source Full Name:Journal of the American Heart Association
-
End Date:20250630
-
Collection(s):
-
Main Document Checksum:urn:sha-512:e1f4f2835c977511998a27b597d5dea1f5324d0450e81bc0946fad01ae75066b0769f64e66a6771bba94347b2f2d6d33013ec21f08be98db6a2addea27ed2a8b
-
Download URL:
-
File Type:
ON THIS PAGE
CDC STACKS serves as an archival repository of CDC-published products including
scientific findings,
journal articles, guidelines, recommendations, or other public health information authored or
co-authored by CDC or funded partners.
As a repository, CDC STACKS retains documents in their original published format to ensure public access to scientific information.
As a repository, CDC STACKS retains documents in their original published format to ensure public access to scientific information.
You May Also Like